Anebulo Pharmaceuticals Stock Analysis

Anebulo Stock Analysis Notes

About 65.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.41. Anebulo Pharmaceuticals had not issued any dividends in recent years. Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. The company was incorporated in 2020 and is based in Lakeway, Texas. Anebulo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Anebulo Pharmaceuticals please contact Richard Cunningham at (512) 598-0931 or go to https://www.anebulo.com.

Anebulo Pharmaceuticals Investment Alerts

Anebulo Pharmaceuticals Upcoming and Recent Events

Anebulo Largest EPS Surprises

View All Earnings Estimates

Anebulo Stock Institutional Investors

Note, although Anebulo Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anebulo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anebulo Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Anebulo Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Anebulo Profitablity

Management Efficiency

Anebulo Pharmaceuticals has return on total asset (ROA) of (0.5465) % which means that it has lost $0.5465 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9537) %, meaning that it created substantial loss on money invested by shareholders. Anebulo Pharmaceuticals' management efficiency ratios could be used to measure how well Anebulo Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of May 9, 2024, Return On Tangible Assets is expected to decline to -1.21. The current year's Return On Capital Employed is expected to grow to -1.16. At present, Anebulo Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 12.9 M, whereas Non Current Assets Total are forecasted to decline to 0.00.

Technical Drivers

As of the 9th of May, Anebulo Pharmaceuticals shows the mean deviation of 2.91, and Risk Adjusted Performance of 0.0613. Anebulo Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Anebulo Pharmaceuticals, which can be compared to its peers. Please confirm Anebulo Pharmaceuticals variance, maximum drawdown, and the relationship between the coefficient of variation and jensen alpha to decide if Anebulo Pharmaceuticals is priced correctly, providing market reflects its regular price of 3.04 per share. Given that Anebulo Pharmaceuticals has jensen alpha of 0.4522, we suggest you to validate Anebulo Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.

Anebulo Pharmaceuticals Price Movement Analysis

Anebulo Pharmaceuticals Insider Trading Activities

Anebulo Pharmaceuticals Predictive Daily Indicators

Anebulo Pharmaceuticals Corporate Filings

Anebulo Pharmaceuticals Forecast Models

Anebulo Pharmaceuticals' time-series forecasting models are one of many Anebulo Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anebulo Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anebulo Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anebulo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anebulo Pharmaceuticals. By using and applying Anebulo Stock analysis, traders can create a robust methodology for identifying Anebulo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anebulo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anebulo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Anebulo Pharmaceuticals stock analysis indicators help investors evaluate how Anebulo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anebulo Pharmaceuticals shares will generate the highest return on investment. By understating and applying Anebulo Pharmaceuticals stock analysis, traders can identify Anebulo Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.Note that the Anebulo Pharmaceuticals information on this page should be used as a complementary analysis to other Anebulo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Anebulo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.